Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide F Precone

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Vaccine|December 13, 2002
Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosisGiovanni B Gaeta, Gianfranca Stornaiuolo, Davide F Precone, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 17, 2004
Case report: effect of antileishmanial treatment on hepatitis C viraemia in a visceral leishmaniasis patient with chronic hepatitis CDavide F Precone, Gianfranca Stornaiuolo, Domenico Galante, et al.
Journal of Hepatology|December 15, 2005
Multiple viral infectionsGiovanni B Gaeta, Davide F Precone, Alessandro Cozzi-Lepri, et al.
Journal of Hepatology|December 4, 2003
Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian studyGiovanni B Gaeta, Gianfranca Stornaiuolo, Davide F Precone, et al.
American Heart Journal|August 2, 2003
Risk factors for "major" embolic events in hospitalized patients with infective endocarditisEmanuele Durante Mangoni, Luigi E Adinolfi, Marie-Francoise Tripodi, et al.
Cancer|December 6, 2002
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective studyGherardo Mazziotti, Francesca Sorvillo, Filomena Morisco, et al.
Journal of Hepatology|June 22, 2002
Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)Claudio Puoti, Roberto Castellacci, Fabrizio Montagnese, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Vaccine|December 13, 2002
Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosisGiovanni B Gaeta, Gianfranca Stornaiuolo, Davide F Precone, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 17, 2004
Case report: effect of antileishmanial treatment on hepatitis C viraemia in a visceral leishmaniasis patient with chronic hepatitis CDavide F Precone, Gianfranca Stornaiuolo, Domenico Galante, et al.
Journal of Hepatology|December 15, 2005
Multiple viral infectionsGiovanni B Gaeta, Davide F Precone, Alessandro Cozzi-Lepri, et al.
Journal of Hepatology|December 4, 2003
Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian studyGiovanni B Gaeta, Gianfranca Stornaiuolo, Davide F Precone, et al.
American Heart Journal|August 2, 2003
Risk factors for "major" embolic events in hospitalized patients with infective endocarditisEmanuele Durante Mangoni, Luigi E Adinolfi, Marie-Francoise Tripodi, et al.
Cancer|December 6, 2002
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective studyGherardo Mazziotti, Francesca Sorvillo, Filomena Morisco, et al.
Journal of Hepatology|June 22, 2002
Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)Claudio Puoti, Roberto Castellacci, Fabrizio Montagnese, et al.
Pageof 1